Doctor Tong Liu

Doctor Tong Liu

2nd Hospital of Tianjin Medical University, Tianjin (China)

Member of:

I currently served as Professor of Cardiology in Tianjin Medical University; Deputy director of Tianjin Institute of Cardiology and an electrophysiologist in Department of Cardiology, Second Hospital of Tianjin Medical University, 300211, Tianjin, P.R. China. My current interests concern the study of atrial fibrillation and arrhythmias. Secondly. I also participate in some researches in the field of Cardio-oncology and heart failure. Furthermore, I have participated in several clinical research protocols that cover a wide range of issues in Cardiology and Internal Medicine. I have published more than 200 papers in Peer-reviewed medical journals, including 110 papers with first/co-first/corresponding/co-corresponding authors. I am on the editorial board of Pacing Clin Electrophysiol, BMC Cardiovascular Disorders, Cardiovascular Diagnosis and Therapy, Frontiers in Physiology, BioMed Research International, Cardiology Research Practice.

Presentations Articles

Biomineralized ceria nanoparticles target the heart to improve diabetic cardiac remodeling by regulating mitochondrial oxidative stress and decreasing excessive mitophagy

Event: ESC Congress 2023

Topic: Ventricular Remodelling

Session: Pathophysiology of heart failure: basic mechanisms

Access

Biomimetic nanozymes target the heart to suppress ferroptosis for ameliorating doxorubicin-induced cardiotoxicity via synergetic effect of antioxidant stress and Nrf2/Hmox1 inhibition

Event: ESC Congress 2023

Topic: Cardio-Oncology

Session: Basic research in cardio-oncology

Access

Protective effects of nicotinamide mononucleotide on radiation-related cardiac injury

Event: ESC Congress 2023

Topic: Cardio-Oncology

Session: Basic research in cardio-oncology

Access

VCAM-1 accelerates atrial remodeling in TERT-/- mice

Event: ESC Congress 2023

Topic: Cellular Mechanisms of Arrhythmias

Session: Pathophysiology and mechanisms of cardiac arrhythmias

Access

Reg3 dependent accumulation of macrophages in aging related atrial fibrillation

Event: ESC Congress 2023

Topic: Cellular Mechanisms of Arrhythmias

Session: Pathophysiology and mechanisms of cardiac arrhythmias

Access

New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase 4 inhibitors: A Chinese population-based cohort study

Event: ESC Congress 2023

Topic: Prevention

Session: Sinus node dysfunction, syncope and cardioneuroablation: what’s new?

Access

IP3R1/GRP75/VDAC1 complex mediated endoplasmic reticulum stress-mitochondrial oxidative stress in diabetic atrial remodeling

Event: EHRA 2021

Topic: Arrhythmias

Session: Pathophysiology of arrhythmias

Access

Three-dimensional vectorcardiographic characteristics of breast cancer patients treated with chemotherapy

Event: EHRA 2021

Topic: Electrocardiography (ECG)

Session: ePoster session

Access

Cancer and risk of atrial fibrillation: a systematic review and meta-analysis.

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Comorbidities and mortalities

Access

Alogliptin, a DPP-4 inhibitor, alleviates atrial remodeling and improves mitochondrial function and biogenesis in diabetic rabbits

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation obesity

Access

Doctor Tong Liu

Biography

Contributor content

Biomineralized ceria nanoparticles target the heart to improve diabetic cardiac remodeling by regulating mitochondrial oxidative stress and decreasing excessive mitophagy

Biomimetic nanozymes target the heart to suppress ferroptosis for ameliorating doxorubicin-induced cardiotoxicity via synergetic effect of antioxidant stress and Nrf2/Hmox1 inhibition

Protective effects of nicotinamide mononucleotide on radiation-related cardiac injury

VCAM-1 accelerates atrial remodeling in TERT-/- mice

Reg3 dependent accumulation of macrophages in aging related atrial fibrillation

New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase 4 inhibitors: A Chinese population-based cohort study

IP3R1/GRP75/VDAC1 complex mediated endoplasmic reticulum stress-mitochondrial oxidative stress in diabetic atrial remodeling

Three-dimensional vectorcardiographic characteristics of breast cancer patients treated with chemotherapy

Cancer and risk of atrial fibrillation: a systematic review and meta-analysis.

Alogliptin, a DPP-4 inhibitor, alleviates atrial remodeling and improves mitochondrial function and biogenesis in diabetic rabbits

ESC 365 is supported by